Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.62M Buy
21,629
+1,282
+6% +$148K 0.33% 73
2025
Q4
$2.16M Sell
20,347
-898
-4% -$84.3K 0.28% 86
2025
Q3
$1.8M Sell
21,245
-2,552
-11% -$210K 0.21% 123
2025
Q2
$1.9M Sell
23,797
-976
-4% -$77.6K 0.23% 114
2025
Q1
$2.23M Buy
24,773
+192
+0.8% +$17.9K 0.27% 101
2024
Q4
$2.47M Buy
24,581
+3,009
+14% +$310K 0.3% 87
2024
Q3
$2.47M Buy
21,572
+357
+2% +$42.4K 0.34% 76
2024
Q2
$2.64M Buy
21,215
+1,020
+5% +$131K 0.39% 68
2024
Q1
$2.68M Buy
20,195
+3,045
+18% +$375K 0.44% 61
2023
Q4
$1.88M Buy
17,150
+1,544
+10% +$160K 0.38% 70
2023
Q3
$1.62M Buy
15,606
+846
+6% +$91.2K 0.39% 63
2023
Q2
$1.71M Buy
14,760
+1,814
+14% +$206K 0.44% 56
2023
Q1
$1.38M Buy
12,946
+2,629
+25% +$284K 0.48% 49
2022
Q4
$1.12M Buy
10,317
+547
+6% +$55.9K 0.31% 80
2022
Q3
$848K Buy
9,770
+628
+7% +$56.1K 0.35% 64
2022
Q2
$835K Buy
+9,142
New +$810K 0.34% 69

Other funds holding MRK

Naviter Wealth's MRK Position: Q1 2026 in Review

Naviter Wealth increased its Merck (MRK) stake by 6.3% in Q1 2026, buying an estimated $148K and bringing the position to 21,629 shares worth $2.62M. The position accounts for 0.33% of the portfolio, ranked #73.

Naviter Wealth first reported a position in MRK in Q2 2022 and has held it in 16 quarters since. The position peaked at $2.68M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Naviter Wealth held 21,629 shares of Merck worth $2.62M as of Q1 2026.
  • Naviter Wealth bought 1,282 Merck shares in Q1 2026, an estimated $148K.
  • Merck made up 0.33% of Naviter Wealth's portfolio in Q1 2026, its #73 holding.
  • Naviter Wealth first reported a position in Merck in Q2 2022 and has held it in 16 quarters since.
  • Naviter Wealth's Merck position peaked at $2.68M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Naviter Wealth's 13F filing for Q1 2026, filed 10 Apr 2026.